Related Parties (Details Narrative) |
6 Months Ended | |||
---|---|---|---|---|
Jun. 03, 2020
USD ($)
shares
|
May 31, 2020
USD ($)
shares
|
Jun. 30, 2020
USD ($)
|
Jun. 30, 2019
USD ($)
|
|
Common stock issued | shares | 50,000 | |||
Issuance of common stock | ||||
Stock option exercise | shares | 5,500,000 | |||
Stock option exercise price | 0.55 | |||
Option vests shares immediate | shares | 1,500,000 | |||
Share-based compensation | 3,009,000 | $ 15,000 | ||
Second Vesting Date [Member] | ||||
Option vests shares immediate | shares | 1,000,000 | |||
Three Year Second Vesting Date [Member] | ||||
Option vests shares immediate | shares | 3,000,000 | |||
Employment Agreement [Member] | First Year [Member] | ||||
Base salary to be paid | $ 120,000 | |||
Employment Agreement [Member] | Second Year [Member] | ||||
Base salary to be paid | 240,000 | |||
Employment Agreement [Member] | Third Year [Member] | ||||
Base salary to be paid | $ 300,000 | |||
Mr Craig Filins [Member] | ||||
Common stock issued | shares | 2,000,000 | |||
Separation and release agreement disclosure | On June 3, 2020, the Company entered into a Separation and Release Agreement with Craig Ellins (the "Separation Agreement"), pursuant to which Mr. Ellins resigned from all of his positions with the Company and its subsidiaries, including his positions as Chief Executive Officer and Chairman of the Board of the Company. Pursuant to the Separation Agreement, the Company (i) issued Mr. Ellins 2,000,000 shares of the Company's Common Stock, (ii) reimbursed Mr. Ellins for $55,000 of expenses previously incurred by him on behalf of the Company, and (iii) agreed to make 12 monthly payments to Mr. Ellins in the amount of $8,000 each in the 12-month period following the date on which the Company has raised $1.5 million in gross proceeds from the sale of its securities following the date of the Separation Agreement. | |||
Mr Thomas's Salary [Member] | ||||
Sale of securities | $ 1,500,000 | |||
Interest rate | 1.25% | |||
Mr Thomas [Member] | ||||
Issuance of common stock | $ 500,000 | |||
Officers and Directors [Member] | ||||
Issuance of common stock | $ 120,000 | |||
Issuance of common stock, shares | shares | 350,000 | |||
Dr Ken Perego [Member] | ||||
Stock option exercise price | 0.56 | |||
Stock option shares awarded option to purchase | shares | 350,000 | |||
Disclosure of common stock options issued for services, directors | The Options will vest as to 1,500,000 shares immediately, as to 116,667 shares immediately, with the remaining 233,333 shares quarterly over the following two years, beginning October 1, 2020. The estimated value using the Black-Scholes Pricing Model, based on a volatility rate of 195% and a call option value of $0.5510, was $192,833. | |||
Stock option volatility rate | 195.00% | |||
Share-based compensation | 69,346 | |||
Unamortized expenses | 123,487 | |||
Bruce Raben [Member] | ||||
Stock option exercise price | 0.56 | |||
Stock option shares awarded option to purchase | shares | 350,000 | |||
Disclosure of common stock options issued for services, directors | The Options will vest as to 1,500,000 shares immediately, as to 116,667 shares immediately, with the remaining 233,333 shares quarterly over the following two years, beginning October 1, 2020. The estimated value using the Black-Scholes Pricing Model, based on a volatility rate of 195% and a call option value of $0.5510, was $192,833. | |||
Stock option volatility rate | 195.00% | |||
Share-based compensation | $ 69,346 | |||
Unamortized expenses | $ 123,487 |